S2 - Neuroimaging in MS

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): MS and CNS Inflammatory Disease
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome Naila Makhani, MD
Disclosure:
Dr. Makhani has nothing to disclose.

1:12 PM 002 Longitudinal Assessment of Cervical Cord Atrophy Across MS Clinical Phenotypes: A Multicenter Study Maria A. Rocca
Disclosure:
Dr. Rocca has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis, Teva Neurosciences and Genzyme.

1:24 PM 003 Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis Regina Schlaeger
Disclosure:
Dr. Schlaeger has nothing to disclose.

1:36 PM 004 Thalamic MRI and histopathologic correlations in advanced multiple sclerosis Kedar Mahajan
Disclosure:
Dr. Mahajan has nothing to disclose.

1:48 PM 005 In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg
Disclosure:
Dr. Granberg has nothing to disclose.

2:00 PM 006 Structural Connectivity Shapes Patterns of Cortical Atrophy in Multiple Sclerosis Kevin Patel, MD
Disclosure:
Dr. Patel has nothing to disclose.

2:12 PM 007 Prevalence of Leptomeningeal Contract Enhancement in Multiple Sclerosis Versus Other Chronic Neuroinflammatory Diseases Martina Absinta, MD
Disclosure:
Dr. Absinta has nothing to disclose.

2:24 PM 008 Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Post-Contrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis Deepa Ramasamy
Disclosure:
Dr. Zivadinov has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Serono, Genzyme-Sanofi, Claret Medical, Celgene and Novartis. Dr. Zivadinov has received research support from RZ received financial support for research activities from Genzyme-Sanofi, Novartis, Claret Medical, Intekrin-Coherus and Quintiles IMS.

Register Now

Related Courses